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ABSTRACT: Here, we report a β-galactosidase (β-Gal) responsive photochromic fluorescent probe NpG that was designed to pre-
bind to human serum albumin (HSA) to form a probe/ protein hybrid NpG@HSA. The formation of NpG@HSA led to an increase 
in fluorescence emission (525 nm) corresponding to the binding of the fluorescent naphthalimide unit with HSA. In addition, this 
enabled visualization of the spiropyran fluorescence emission in aqueous media. Our probe/protein hybrid approach afforded a unique 
imaging platform with enhanced cell permeability and solubility that was capable of visualizing the cellular uptake of NpG@HSA 
before its activation by β-Gal. The β-Gal-mediated cleavage of the galactose unit within the NpG@HSA hybrid resulted in the 
formation of NpM@HSA and an increase in red fluorescence emission (620 nm). The resultant merocyanine unit was then able to 
undergo photoisomerization (merocyanine↔spiropyran) facilitating STORM (i.e. Stochastic Optical Reconstruction Microscopy) 
imaging with minimal phototoxicity and excellent photostability/reversibility. Using STORM, NpG@HSA was able to determine 
the subcellular distribution of β-Gal activity between cell lines with nanoscale precision. We believe this system represents a versatile 
imaging platform for the design of photochromic fluorescent probes suitable for illuminating the precise location of disease-specific 
biomarkers in various cellular processes.
INTRODUCTION 
Enzymes are essential for the modification of a wide range of 
biologically important substrates.1-2 This includes the post-
translational modification of proteins and biomolecules that are 
directly involved in a number of key cellular events such as cell 
cycle, cell-cell interaction, signal transduction, and pro-
grammed cell death (apoptosis, proptosis and ferroptosis).2-4 As 
a result, abnormal enzymatic activity has been linked to a range 
of diseases, which include inflammation, cancer and neuro-
degenerative disorders.5-7 This dysregulation of an enzyme’s ac-
tivity can occur through a multitude of mechanisms, including 
simple changes to the physiological environment or by its sub-
cellular distribution.8 Therefore, identifying an enzyme’s pre-
cise distribution and regulatory mechanisms within a specific 
cellular environment provides the foundation for identifying the 
relationship between its expression and a pathological process.9-
10 Despite the significant advancements made in the field of flu-
orescence sensing, the ability to determine the exact intracellu-
lar localization of an enzyme remains a challenging task, due to 
the diffraction limit of light and unsatisfactory spatial/temporal 
resolution of the currently reported fluorescent probes.11-13  
The recent development of super-resolution-based technologies 
have revolutionized fluorescence-based imaging with the 
ability to visualize basic cellular structures with nanoscale 
precision by overcoming the diffraction limit of light.14-18 
Amongst the current super-resolution techniques, STORM 
(Stochastic Optical Reconstruction Microscopy) and PALM 
(photoactivated localization microscopy) rely on the use of 
fluorophores with switchable fluorescence emission profiles 
(photo-blinking).15-17, 19-22 In these techniques, STORM/PALM 
facilitate the separation of spatially overlapping images of 
individual molecules to precisely determine their location. 
These techniques have enabled the super-resolution imaging of 
cellular architectures (e.g. tubulin)23-25 and organelles such as 
mitochondria26 and lysosomes.27 More recently, 
STORM/PALM-based fluorescent probes have been reported 
for the detection of disease-related biomarkers.28-29 These re-
ported strategies rely on a dual-activatable approach (AND-
logic) using a photoactivatable diazoindanone-based unit and 
enzyme cleavable motif, combined onto a single xanthene scaf-
fold. Therefore, in the presence of a specific biomarker “AND” 
light, the probe is irreversibly photoactivated to afford a fluo-
rescent product. The fluorescent product is then switched “off” 
by photobleaching before another subset is switched on. Repe-
tition of this process allows for a super-resolution image to be 
constructed from a large number of individual molecular local-
izations. However, this photoinduced deprotection strategy 
combined with photobleaching could result in unwanted tox-
icity/phototoxicity issues, thus adversely affecting the 
 
 
biological study in question.30 Therefore, a reversible pho-
toswitching system is highly desirable as it allows the same ac-
tivated fluorophore to undergo multiple photoswitching cycles 
to obtain a super-resolution image with potentially less toxicity 
issues. 
Spiropyran-based photochromic dyes (merocyanine↔spiropy-
ran)31 have been used as effective dyes for the super resolution 
imaging of cellular components32 displaying excellent pho-
toswitching properties, low photobleaching kinetics and mini-
mal phototoxcitiy.32-34 Such examples include the use of 
photoactuated unimolecular logical switching attained 
reconstruction (PULSAR) microscopy.32 Unfortunately, the 
poor aqueous solubility of these photochromophores often 
results in their aggregation-caused quenching (ACQ), which 
has limited their biological application (Scheme 1a).35 We are 
particularly interested in exploring the potential use of 
spiropyrans for biological applications, and as such we have 
previously developed functional spiropyran dyes containing 
ligands that allow the targeted imaging of disease specific cell 
lines with the additional ability to “double check” the dyes 
cellular uptake.35, 36 
Inspired by these previous reports coupled with our interests in 
the development of fluorescent probes and super-resolution 
imaging technology,37-40 we envisioned functionalizing the free 
phenol motif on the merocyanine fluorophore with an enzyme 
responsive unit would prevent photoisomerization and quench 
the fluorescence emission to afford an enzyme-based STORM 
fluorescent probe. In addition, we believed the incorporation of 
afluorescent naphthalimide unit would facilitate human serum 
albumin (HSA) binding and as a result provide appropriate 
aqueous solubility, cell permeability and allow the visualization 
of the cellular uptake of the STORM probe before its activation. 
Moreover, a clear fluorescence emission signal would be 
observed from the merocyanine unit upon activation(Scheme 
1b).35, 41, 42 In this study, we have chosen β-galactosidase (β-Gal) 
as a relevant example, however, it is important to note that the 
β-Gal reactive unit could be replaced with a reactive motif of 
choice to detect other biologically important biomarkers (i.e. 
H2O2, Esterases, proteases). 
Here, a β-Gal-functionalized merocyanine fluorescent sensor 
NpG has been developed that was specifically designed to bind 
to human serum albumin (HSA) (Scheme 1a). In the presence 
of HSA, NpG formed a probe/ protein hybrid NpG@HSA, 
leading to an increase in fluorescence emission (525 nm), which 
corresponded to the binding of HSA with the fluorescent naph-
thalimide unit. This allowed the visualization of the cell uptake 
of NpG@HSA. Prior to activation, galactose-caged 
NpG@HSA was non-fluorescent at 620 nm and was unable to 
under-go photoisomerization. The β-Gal-mediated cleavage of 
the galactose unit resulted in the release of NpM@HSA with a 
concomitant increase in red fluorescence emission (620 nm). 
The release of the free phenol of NpM@HSA activated the sys-
tem towards photoisomerization. The reversible photoisomeri-
zation and ON/OFF photo-blinking was then used for STORM 
imaging, which enabled the visualization of the subcellular lo-




Scheme 1. (a) Photochromic spiropyran dye for reversible photoswitching applications.31 (b) Structure and (c) fluorescence “turn-on” mechanism of 
NpG@HSA for the monitoring of β-Gal with the super-resolution imaging technique, STORM. 
RESULTS AND DISCUSSION  
In brief, NpG was synthesized by condensing a 2, 3, 3-trime-
thyl-3H-indole functionalized naphthalimide with 5-
nitrosalicylaldehyde that was modified with an acetyl protected 
β-galactose group on the phenol unit. The subsequent 
deprotection of the acetate groups afforded NpG (Scheme S1). 
NpS was synthesized (Scheme S1) for use as a control in 
subsequent experiments. The protein hybridisation of NpG with 
HSA to form NpG@HSA was carried out as previously 
 
 
reported and verified by fluorescence spectroscopy. The 
addition of HSA (0 – 50 μΜ) to a solution of NpG (5 μM) led 
to a remarkable increase in green fluorescence emssion (520 
nm) corresponding to the formation of the probe/protein hybrid 
NpG@HSA (Figure S1a) (Figure S2).43 This increase in 
fluorescence emission was indicative of the inclusion of NpG 
into the hydrophobic pocket of HSA owing to the enviromental 
sensitive nature of the fluorescent naphthalimide unit.44 Job’s 
plot analysis and competition-based experiments revealed a 
binding stoichiometry of 1:1 (Figure S1b) and a predominant 
inclusion into Site 1 (IIA domain) of HSA.43 Isothermal titration 
calorimetry (ITC) and small angle X-ray scattering (SAXS) 
were carried out to further confirm these observations. As 
shown in Figure S1c and Figure S1d, a strong binding between 
NpG and HSA was observed with a binding affinity of Kd = 
27.34 ± 1.93 μM. SAXS analysis demonstrated a substantial 
conformational change of the probe/protein hybrid at Site 1 
(Figure S3). The fluorescence emission of NpG@HSA was 
shown to decrease when treated with a Site 1 binding drug 
(phenylbutazone), thus confirming our opinion that 
NpG@HSA was included in Site 1 of HSA (see ESI for SAXS 
data).38, 41  
Next, we turned our attention towards the evaluation of 
NpG@HSA to selectively detect β-Gal in PBS buffer (10 mM, 
pH = 7.40). In the presence of β-Gal (10 U/mL), a decrease in 
UV-Vis absorption at 400 nm with a concomitant increase in 
the UV-Vis absorption at 530 nm was observed after 30 min 
(Figure 1a). This change in the UV-Vis absorption was accom-
panied with a significant increase in fluorescence emission in-
tensity at 620 nm (Figure 1b and Figure S4a). High-perfor-
mance liquid chromatography (HPLC) and high-resolution 
mass spectrometry (HRMS) (Figure S5) confirmed the changes 
in photophysical properties were the result of the β-Gal-medi-
ated cleavage of NpG@HSA to NpM@HSA. Through fluores-
cence titrations, the limit of detection (LOD) was calculated as 
6.1 × 10-4 U/mL (Figure 1c and Figure S4b). The steady-state 
kinetics of β-Gal towards NpG@HSA were determined using 
fluorescence spectroscopy, with the resultant fluorescence data 
analyzed using the Michaelis-Menten equation. A typical Mich-
aelis-Menten curve was obtained (Figure S4c), which revealed 
a Michaelis-Menten constant of Km = 4.34 μM and a Vmax of 
23.37 nM/s) (see SI for details). The selectivity of NpG@HSA 
towards other biological relevant species was then determined 
to demonstrate its applicability in bioimaging applications. As 
shown in Figure 1d, NpG@HSA exhibited high substrate se-
lectivity for β-Gal over small-molecular metabolites and other 
glycosidases including β-glucosidase and β-glucoronidase. 
 
Figure 1 – The (a) time-dependent UV-Vis absorption and (b) fluorescence 
emission changes over time of NpG@HSA (5 μM) after incubation with β-
Gal (10 U/mL) in PBS buffer (10 mM, pH = 7.4, 0.5% DMSO), respec-
tively. Blue line: 0 min; Red line: 30 min. (c) Plots and linear fit of the 
fluorescence intensity of NpM@HSA at 620 nm as a function of β-Gal con-
centration (0-10 U/mL) after 30 min of incubation. (d) Fluorescence change 
at 620 nm of NpG@HSA with various biomolecules or enzymes after in-
cubation for 30 min in PBS buffer (10 mM, pH = 7.4, 0.5% DMSO). H2O2 
(0.1 mM), ClO- (0.1 mM), .OH (0.1 mM), ATP (0.1 mM), tyrosine (Tyr, 0.1 
mM), tryptophan (Trp, 0.1 mM), -glucosidase (10 U/mL), -glucuronidase 
(10 U/mL), ALP (10 U/mL), lysozyme (10 U/mL), cellulase (10 U/mL), 
esterase (10 U/mL). All emissions were produced upon excitation at 530 
nm. 
Light-based experiments were then performed to determine the 
reversible photoisomerization ability of NpM@HSA. As 
shown in Figure 2a and Figure 2b, upon irradiation of 
NpM@HSA with visible light (550 nm, 150 mW cm-2, 1 min), 
the fluorescence emission (620 nm) and UV-Vis absorption 
(530 nm) corresponding to NpM@HSA decreased sharply. 
HPLC analysis confirmed (Figure S5a), this was the 
photoisomerization of merocyanine (NpM) to the colorless, 
non-fluorescent spiropyran isomer (NpS). Subsequent UV 
irradiation (365 nm, 160 mW cm-2, 5 min) of the same solution 
led to the regeneration of the photophysical properties unique 
to NpM@HSA, which corresponds to the photostationary state 
(PSS) of NpS. Several photoswitching cycles alternating visible 
(550 nm) and UV (365 nm) light irradiation (Figure 2c and 
Figure 2d) illustrated the excellent photostability of 





Figure 2 – The (a) UV-Vis absorption and (b) fluorescence emission 
changes of NpM@HSA upon irradiation with alternate visible light (550 
nm, 150 mW cm-2, 1 min) and UV light (365 nm, 160 mW cm-2, 5 min), 
respectively. Red line: NpM@HSA; Blue line: Upon irradiation with 550 
nm visible light for 1 min (mainly in the spiropyran isomer); Yellow line: 
Photostationary state (PSS) after irradiation of UV light for 5 min. (c) 
Photo-fatigue resistance performances of the UV-Vis absorption at 540 nm 
and (d) fluorescence emission at 620 nm of NpM@HSA upon irradiation 
with alternate visible light (550 nm, 150 mW cm-2, 1 min) and UV light 
(365 nm, 160 mW cm-2, 5 min), respectively. All emissions were produced 
upon excitation at 530 nm. 
Cellular imaging experiments were carried out using the pre-
formed probe/protein hybrid, NpG@HSA to examine its ability 
to image endogenous β-Gal. The treatment of human ovarian 
carcinoma cells (SKOV-3 cells), a cell line known to overex-
press β-Gal with NpG@HSA,45-47 led to fluorescence emissions 
corresponding to both naphthalimide (520 nm, green) and mer-
ocyanine (620 nm, red) being observed (Figure 3a). In contrast, 
pre-treatment of SKOV-3 cells with excess D-galactose – 1 mM 
(β-Gal inhibitor) prior to the addition of NpG@HSA resulted 
in only green fluorescence emission being observed. This was 
taken as evidence that the increase in red fluorescence emission 
in the absence of D-galactose is due to endogenous β-Gal (Fig-
ure 3a). Overall, these experiments demonstrate the excellent 




Figure 3 - β-Gal-activated fluorescence “OFF-ON” imaging in live cells of 
NpG@HSA (a) Confocal imaging of SKOV-3 cells incubated with 
NpG@HSA (20 μM) for 40 min with or without preincubated D-galactose 
(1 mM) as an inhibitor. (b) Confocal imaging of WI-38 cells incubated with 
NpG@HSA (20 μM) for 40 min with or without treatment by ionizing ra-
diation (IR, 12 Gy). Green channel: Ex/Em = 488 / 530-540 nm; Red chan-
nel: Ex/Em = 559 / 600-620 nm. 
With these results in hand, the ability of NpG@HSA to differ-
entiate between the β-Gal activity of ovarian cancer and normal 
cell lines was then evaluated. The three different cell lines, 
OVCAR-3, SKOV-3 and HUVEC were chosen and treated with 
NpG@HSA. As shown in Figure S6, each cell line displayed 
significant green fluorescence emission further demonstrating 
the excellent cell permeability of NpG@HSA and utility of the 
probe/protein hybrid to visualize cellular uptake. As expected, 
a clear red fluorescence emission was observed in both ovarian 
cancer cells OVCAR-3 and SKOV-3, whereas HUVEC, a hu-
man umbilical vein endothelium cell line displayed only green 
fluorescence emission. This result further demonstrates the 
unique ability of the imaging platform to simultaneously visu-
alize cellular uptake and monitor enzymatic activity within var-
ious cell lines thus removing any potential false negatives. 
To demonstrate the full potential of NpG@HSA for 
monitioring intracellular β-Gal, we then evaluated its ability to 
visualise changes in β-Gal levels during cell senescence. In 
these experiments, WI-38 cells (human embryonic lung diploid 
fibroblasts) were incubated with NpG@HSA. Similar to 
previous experiments, WI-38 cells displayed initial green 
fluorescence emission (Figure 3b, green channel). Then, as 
predicted, no red fluorescence emission was observed (Figure 
3b, red channel), due to low endogeous levels of β-Gal being 
present in WI-38 cells. However, treatment of WI-38 cells with 
ionizing radiation (IR, 12 Gy, 24 h)) induced cell senescence,48-
50 and led to a significant enhancement in red fluorescence 
emission, which was indicative of an increase in β-Gal levels 
(Figure 3b,). A commercial β-Gal biochemical assay was used 
to confirm the increase in red fluorescence emission in WI-38 
cells exposed to ionising irradiation was the result of an increase 
in β-Gal expression (Figure S7). Again, these results are in 
 
 
agreement with previous reports that β-Gal is overexpressed in 
senescent cells.51 Note - hydrogen peroxide (H2O2) (150 μM, 2 
h) was shown as an alternative strategy to induce cell 
senescence and increase β-Gal expression (Figure S7).50 H2O2 
was used as an additional cell senescence inducing strategy due 
to the shorter time periods required to induce cell senescence in 
comparison to the ionising irradiation protocol (H2O2 – 12/ 48 h 
vs IR – 12 days). 
Subsequently, visible/UV light irradiation of both SKOV-3 and 
senescent cells was carried out, and a reversible “ON/OFF” 
change in the fluorescence signal was observed (Figure 4a, and 
Figure 4c). Remarkably, the “photo-blinking” effect was re-
peated over several cycles with no obvious change in fluores-
cence intensity (Figure 4b and Figure 4d). Both D-galactose 
pre-treated SKOV-3 cells and non-irradiated WI-38 cells pro-
duce no red fluorescence emission nor photo-blinking, irrespec-
tive of either UV or visible irradiation (Figure 4a, and Figure 
4c). In addition, NpG@HSA displayed almost no cytotoxicity 
(Figure S8a) including no phototoxicity for the photo-switching 
experiments (UV light: 365 nm, 160 mW cm-2, 5 min per cycle 
and visible light: 550 nm, 150 mW cm-2, 10 min per cycle; Fig-
ure S8b).  
 
Figure 4 - (a) Fluorescence imaging of SKOV-3 cells incubated with NpG@HSA (20 μM) for 40 min in the absence (line 1) and presence of D-galactose (1 
mM, line 2) upon alternate irradiation with UV and visible light. (b) Fluorescence quantification of the images shown in Fig. 4a with photoswitching cycles. 
(c) Fluorescence imaging of endogenous β-Gal in WI-38 cells with or without ionizing irradiation after incubation with NpG@HSA (20 μM) for 40 min. (d) 
Fluorescence quantification of the images shown in Fig. 4d with photoswitching cycles. Green channel: Ex/Em = 488 / 530-540 nm; Red channel: Ex/Em = 
559 / 600-620 nm. For photoswitching excitation: UV, 405 nm, 30 s; Vis, 559 nm, 10 min. 
Encouraged by the above results, we then applied our enzyme-
activated NpG@HSA photochromic probe for the STORM-
based imaging of endogenous β-Gal distributions in both ovar-
ian cancer and aging cells. STORM images were recorded on 
an electron multiplying charge-coupled device (EMCCD) cam-
era running at 52-53 ms per frame. After optimization of the 
protocol,18 it was possible to acquire images with enough 
switching events to render meaningful STORM images, the 
number of frames collected was up to 16000 (Figure 5, Figure 
S9 and Video S1). To extract dynamic information from these 
images, the 16000 frames obtained were divided and recon-
structed to examine the gradual increase in the activated fluo-
rescent “hotspot”. The images were separated and reconstructed 
from 0 - 4000 frames (Figure S9a and Figure S9c), 0 - 8000 
frames (Figure S9b and Figure S9d) and 0 - 16000 frames (Fig-
ure 5b and Figure 5f). The red areas shown in Figure 5 and Fig-
ure S9, which are known as clusters indicate when the fluores-
cence intensity is higher than a set threshold fluorescence inten-
sity (two-fold), whereas the green areas/dots represent an inten-
sity below the threshold (green objects). Interestingly, red clus-
ters were shown to become densely populated in senescent WI-
38 cells with a specific distribution as the frame number in-
creased, suggesting the β-Gal in senescent cells is localized 
(Figure 5b, Figure S9a and Figure S9b). On the contrary, in 
SKOV-3 cells, probe-concentrated red clusters were hardly ob-
served with green objects predominating, suggesting a random 
distribution of β-Gal in the cytoplasm (Figure 5f, Figure S9c 
and Figure S9d). Co-localization experiments using 
LysoTracker produced a high Pearson's correlation coefficient 
(0.955) suggesting the localization in senescent cells was at the 
lysosome. This is supported by previous reports.45-47, 51-52 A poor 
Pearson’s correlation efficient (0.496) was observed for SKOV-
3 cells, which further confirmed the random distribution 
throughout the cytoplasm (Figure S10). Remarkably, these 
STORM images displayed a high resolution with an average 
full-width-at-half maximum (FWHM) diameter of 80 nm in 
WI-38 cells (Figure 5c, top and Figure 5d, blue line) and 74 nm 
in SKOV-3 cells (Figure 5g, top and Figure 5h, blue line), 
which are significantly greater when compared with traditional 
confocal fluorescence images (for WI-38 cells, 1 μm, Figure 5c, 
bottom and Figure 5d, red line; for SKOV-3 cells, 4 μm, Figure 
5g, bottom and Figure 5h, red line). These results demonstrate 
 
 
the utility of STORM to provide more detailed information on 
the precise distribution of intracellular β-Gal with greater 
resolution and potentially overcoming the limitations of current 
fluorescent probes. 
 
Figure 5 – Subcellular imaging of β-galactosidase in cancerous and senescent cells using STORM. (a) Super-resolution images (STORM) of senescent WI-
38 cells and (e) SKOV-3 cells incubated with NpG@HSA (20 μM), respectively. (b) Zoomed images of Fig. 5a reconstructed from 16000 frames. Scale bar: 
1 μm. (f) Zoomed images of Fig. 5d reconstructed from 16000 frames. Scale bar: 1 μm. (c-d) The calculation of FWHM in WI-38 cells of STORM image and 
wide image, respectively. (g-h) The calculation of FWHM in SKOV-3 cells of  STORM image and wide image, respectively. 
To validate our results from above, voxels were extracted from 
the fluorescence signals and processed to illustrate the for-
mation of clusters using the algorithm of Cell Membrane 
Detection using the Bitplane Imaris software (Figure S11).53 
The center of each fluorescent signal were labeled as spots and 
each voxel was mapped with an intensity representing the 
distance to the adjacent spot. As shown in Figure S11a and 
Figure S11d, the voxels were divided into different color 
polygons according to the distribution of distance. A gradient 
color change could be observed for the image of senescent WI-
38 cells, indicating a possible existence of clusters. For the 
image of SKOV-3 cells, a randomly distributed emission was 
observed. Zoomed images were reconstructed from 0-8000 
frames (Figure S11b and Figure S11e) and from 0-16000 frames 
(Figure S11c and Figure S11f). The red clusters of polygons in 
the images of senescent WI-38 cells increased remarkably as 
the frame number increases, while the green objects in images 
of SKOV-3 cells remained dominant regardless of the frame 
numbers. The results from these two methods clearly indicate 
that NpG@HSA can be used for the mapping of intracellular β-
Gal activity with high precision using STORM imaging. Over-
all, the results indicate that our design strategy has produced a 
new versatile imaging platform that could be used to develop a 
range of fluorescent probes suitable for STORM-based imaging. 
CONCLUSIONS 
In summary, we have developed an enzyme-responsive photo-
chromic fluorescent probe/ HSA assemble (NpG@HSA) that 
was able to image β-Gal in ovarian cancer and senescent cells. 
NpG@HSA provides enhanced cell permeability and solubility 
facilitating the visualization of cellular uptake. The β-Gal-
mediated deprotection of the galactose unit on NpG@HSA re-
leased the photo-active merocyanine. STORM-based imaging 
of β-Gal in different cell lines was then possible due to the 
excellent photo-switching properties of the merocyanine unit. 
Using STORM imaging, the cellular distribution of β-Gal was 
visualized at an unprecedented nanoscale level. These results 
provide more detailed information on the precise distribution of 
lysosomal β-Gal in senescent cells and the random distribution 
in ovarian cancer cells. We anticipate that our enzyme respon-
sive, photochromic/ protein fluorescent probe strategy will in-
spire others to develop a range of fluorescent probes suitable for 
the super-resolution imaging of disease-related biomarkers. 
METHODS 
Ionizing radiation (IR) induced cell senescence procedures. 
WI-38 cells (human embryonic lung diploid fibroblasts) were 
cultured in 5 % CO2 atmosphere under 37°C in Eagle's Mini-
mum Essential Medium (Sigma, USA) supplemented with 10% 
fetal bovine serum (Gibco, Gland Island, NY, USA). In all ex-
periments, cells at early passages (< 10 passages) were used and 
each of the passage reached approximately 90 % confluence. 
Exponentially-growing WI-38 cells at passage 6 were plated 
into 6 cm cell culture dish (Corning, USA) and after 24 h, these 
cell culture dishes were irradiated with doses of 12 Gy at room 
temperature to induce cell senescence. After irradiation, WI-38 
cells were senescent by day 12 with 90% or more cells positive 
for senescence associated β-galactosidase activity. 
Oxidative stress-induced cell senescence by treatment with 
exogenous H2O2. Exponentially-growing WI-38 cells at pas-
sage 6 were plated into 6 cm cell culture dish (Corning, USA) 
and treated with H2O2 (150 μM, Sinopharm Chemical Reagent 
Co.,Ltd, Shanghai, China) for 2h, followed by 12 h or 48 h con-
tinuous culture. 
Cytochemical staining method. Experiments were performed 
using a senescence β-galactosidase staining kit according to the 
manufacturer’s instructions (Beyotime, Shanghai, China). Cells 
 
 
were plated on 96-well plates in growth medium. After 24 h, the 
cells were washed with PBS and fixed for 15 min. After dilution 
with PBS, the cells were washed again with PBS and stained 
with X-Gal solution for 24 h at 37 ºC. Finally, bright field im-
ages were collected on an Olympus IX71 microscope. 
Confocal laser scanning microscopy for imaging of endoge-
nous β-Gal. Cells cultured in growth medium supplemented 
with 10% FBS were added to a 24-well microplate. Cells were 
maintained in a humidified atmosphere of 5% CO2 and 95% air 
at 37 °C overnight, and then incubated with NpG@HSA (20 
μM) for 40 min. Then the cells on the microplate were rinsed 
using warm PBS and fixed by 4 % paraformaldehyde for 20 min 
at room temperature. Immediately after sealing, the fluores-
cence was detected and photographed with confocal laser scan-
ning microscopy (Olympus, Japan, green channel excitation: 
488 nm, emission: 530-540 nm; red channel excitation: 559 nm, 
emission: 600-620 nm). After imaging of endogenous β-galac-
tosidase with confocal laser scanning microscopy (Olympus, 
Japan, green channel excitation: 488 nm, emission: 530-540 nm; 
red channel excitation: 559 nm, emission: 600-620 nm), the 
slide was irradiated with visible light (559 nm laser) in a dark-
room for 10 min, and then the two channels of fluorescence 
were detected and photographed with the microscope. To test 
the duplexed fluorescence switching, the slide was further irra-
diated with UV light (405 nm laser) in the darkroom for 30 s, 
and then the two channels of fluorescence were detected and 
photographed with the microscope. The UV/Vis irradiation was 
repeatedly carried out for at least three cycles. 
Cell viability and phototoxicity assay. SKOV3 cells (ATCC® 
HTB-77™) were plated on 96-well plates in growth medium 
(McCoy’s 5A; Gibco, Gland Island, NY, USA) for 24 h and 
then treated with different concentrations of NpG@HSA. After 
48 h incubation, MTS/PMS solution was added. After 2 h incu-
bation, the absorbance was measured at 490 nm using a M5 mi-
croplate reader (Molecular Device, USA). The optical density 
from the MTS assay was directly proportional to the number of 
viable cells. For the phototoxicity assay, UV light (365 nm, 160 
mW cm-2, 5 min) and visible light (550 nm, 150 mW cm-2, 10 
min) was used to irradiate alternately for different cycles. Then 
the cells were incubated in dark at 37 ºC for 48 h and the viabil-
ity was measured through the MTS cell proliferation assay. 
Co-localization experiment. Cells cultured in growth medium 
supplemented with 10% FBS were added to a 24-well micro-
plate. Cells were maintained in a humidified atmosphere of 5% 
CO2 and 95% air at 37 °C overnight and were treated using 
H2O2-induced cell senescence assay. Then, cells were incubated 
sequentially with NpG@HSA (20 μM) and LysoTracker® 
Deep Red (500 nM, Thermo Fisher Scientific) for 40 min. Then 
the cells on the microplate were rinsed by warm PBS and fixed 
by 4% paraformaldehyde for 20 min at room temperature. Im-
mediately after sealing, the fluorescence was detected and pho-
tographed with confocal laser scanning microscopy (Leica TCS 
SP8, Leica Microsystems, Wetzlar, Germany, red channel exci-
tation: 559 nm, emission: 600-620 nm; Lyso tracker channel ex-
citation: 633nm, emission: 650-670 nm).  
STORM imaging protocol. Super-resolution STORM imaging 
was performed on a custom modified Nikon N-STORM micro-
scope54 equipped with a motorized inverted microscope 
ECLIPSE Ti-E, an Apochromat TIRF 100 × oil immersion lens 
with a numerical aperture of 1.49 (Nikon), an electron 
multiplying charge-coupled device (EMCCD) camera (iXon3 
DU-897E, Andor Technology), a quad band filter composed of 
a quad line beam splitter (zt405/488/561/640rpc TIRF, Chroma 
Technology Corporation) and a quad line emission filter 
(brightline HC 446, 523, 600, 677, Semrock, Inc.). The TIRF 
angle was adjusted to oblique incidence excitation at the value 
of 3920-3950, allowing the capture of images at about 1 μm 
depth of samples. The focus was kept stable during acquisition 
using Nikon focus system. Before the STORM imaging exper-
iments, we first confirmed the feasibility of merocyanine imag-
ing using total internal reflection (TIRF) excitation at 561 nm 
and detection with a 630/60 nm bandpass filter. Furthermore, 
the photoactivation was proved to be efficient under 405 nm la-
ser irradiation to modulate the photochromic processes. During 
the imaging experiments, the fluorescent state (merocyanine 
isomer) was converted to the dark state (spiro isomer) under 561 
nm visible light . Then, the 405 nm diode laser (CUBE 405-
100C, Coherent Inc.) was used for switching back the fluoro-
phores from dark to the fluorescent state, meanwhile the 561 
nm continuous wave visible fibre laser was used to excite the 
merocyanine isomer for collecting the cell images. The integra-
tion time of the EMCCD camera was 52-53 ms per frame. To 
image intracellular β-galactosidase, cells were seeded on a glass 
dish, and when the density was appropriate, cells were stained 
with NpG@HSA for 40 min and cells were fixed with 4% PFA, 
followed by three washes with PBS buffer. Before imaging, the 
buffer in the dish was replaced with the imaging buffer contain-
ing 7 μL GLOX solution and 500 μL Buffer B (50 mM, Tris-
HCl, pH = 8.0 and 10 % Glucose). 
Analysis of STORM imaging data. Super-resolution images 
were reconstructed from 0-4000 (71s in SKOV-3 and 162 s in 
WI-38 senescent cells), 0-8000 (142s in SKOV-3 and 324 s in 
WI-38 senescent cells) and 16000 frames (285s in SKOV-3 and 
651 s in WI-38 senescent cells) using the N-STORM analysis 
module of NIS Elements AR (Laboratory imaging s.r.o.) and 
then the fluorescence signal of images was processed with the 
Image J software. Clusters were defined as regions where the 
fluorescence intensity is larger than twice the average intensity 
of the whole image and marked red. Objects were defined as 
regions where the fluorescence intensity is lower than twice the 
average intensity of the whole image and marked green. For the 
single-voxel localization analysis, voxels of molecular fluores-
cence signal were localized using the Bitplane Imaris software. 
The centers of signals were labelled as spots and the XTensions 
plug-in of distance transformation computes and creates a new 
channel. The created channel intensity values are based on the 
distance to a spot. Each voxel was mapped with an intensity 
representing the minimum distance measured to the nearest 
spot’s center. A higher intensity value corresponds to a larger 
distance to a spot. The center of the spot defines the origin of 
the distance transformation. Voxels in the center of the spot are 
always set to have an intensity value of 0. The localization of 
voxels was divided into different polygons areas according to 
the distribution of distance by the algorithm of Cell Membrane 
Detection in Imaris. The Polygon area size represents the fluo-
rescence density distribution. Objects were defined as regions 
that enclose polygons in which the area (represents the fluores-
cence density distribution) value is lower than half of the aver-
age area value of the whole image. Clusters were defined as re-
gions in which the area value is lower than quarter of the area 
intensity value of the whole image. 
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